Vollrath, A.; Kretzer, C.; Beringer-Siemers, B.; Shkodra, B.; Czaplewska, J.A.; Bandelli, D.; Stumpf, S.; Hoeppener, S.; Weber, C.; Werz, O.;
et al. Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187. Polymers 2021, 13, 2557.
https://doi.org/10.3390/polym13152557
AMA Style
Vollrath A, Kretzer C, Beringer-Siemers B, Shkodra B, Czaplewska JA, Bandelli D, Stumpf S, Hoeppener S, Weber C, Werz O,
et al. Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187. Polymers. 2021; 13(15):2557.
https://doi.org/10.3390/polym13152557
Chicago/Turabian Style
Vollrath, Antje, Christian Kretzer, Baerbel Beringer-Siemers, Blerina Shkodra, Justyna A. Czaplewska, Damiano Bandelli, Steffi Stumpf, Stephanie Hoeppener, Christine Weber, Oliver Werz,
and et al. 2021. "Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187" Polymers 13, no. 15: 2557.
https://doi.org/10.3390/polym13152557
APA Style
Vollrath, A., Kretzer, C., Beringer-Siemers, B., Shkodra, B., Czaplewska, J. A., Bandelli, D., Stumpf, S., Hoeppener, S., Weber, C., Werz, O., & Schubert, U. S.
(2021). Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187. Polymers, 13(15), 2557.
https://doi.org/10.3390/polym13152557